Kalbe Farma Tbk PT Cash Flow Conversion Efficiency
Kalbe Farma Tbk PT cash flow conversion efficiency. Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.041x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.05 Trillion ≈ $61.81 Million USD) by net assets (Rp25.76 Trillion ≈ $1.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kalbe Farma Tbk PT (2000–2025)
Cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2025. This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View KLBF stock price for real-time trading data and today's change.
Kalbe Farma Tbk PT Cash Flow Conversion Ratio Explained
Kalbe Farma Tbk PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency. Also see KLBF company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EIH Limited
NSE:EIHOTEL
|
0.054x |
|
Xinxing Ductile Iron Pipes Co Ltd
SHE:000778
|
-0.010x |
|
China Meheco Co Ltd
SHG:600056
|
0.016x |
|
FAIRFAX INDIA HLDGS
F:F5X
|
0.007x |
|
Cosmo Electronics Corp
TW:2466
|
-0.020x |
|
VGP NV
BR:VGP
|
-0.006x |
|
Guangxi Guitang Group Co Ltd
SHE:000833
|
0.058x |
|
Anhui Heli Co Ltd
SHG:600761
|
0.035x |
Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2025)
The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2025. Review KLBF free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp24.73 Trillion ≈ $1.45 Billion |
Rp3.27 Trillion ≈ $191.65 Million |
0.132x | -32.03% |
| 2024-12-31 | Rp24.59 Trillion ≈ $1.44 Billion |
Rp4.79 Trillion ≈ $280.39 Million |
0.195x | +54.74% |
| 2023-12-31 | Rp23.12 Trillion ≈ $1.35 Billion |
Rp2.91 Trillion ≈ $170.37 Million |
0.126x | -26.28% |
| 2022-12-31 | Rp22.10 Trillion ≈ $1.29 Billion |
Rp3.77 Trillion ≈ $220.87 Million |
0.171x | +28.37% |
| 2021-12-31 | Rp21.27 Trillion ≈ $1.25 Billion |
Rp2.83 Trillion ≈ $165.59 Million |
0.133x | -42.38% |
| 2020-12-31 | Rp18.28 Trillion ≈ $1.07 Billion |
Rp4.21 Trillion ≈ $246.97 Million |
0.231x | +53.92% |
| 2019-12-31 | Rp16.71 Trillion ≈ $978.88 Million |
Rp2.50 Trillion ≈ $146.66 Million |
0.150x | -17.30% |
| 2018-12-31 | Rp15.29 Trillion ≈ $896.20 Million |
Rp2.77 Trillion ≈ $162.36 Million |
0.181x | +25.33% |
| 2017-12-31 | Rp13.89 Trillion ≈ $814.14 Million |
Rp2.01 Trillion ≈ $117.68 Million |
0.145x | -16.59% |
| 2016-12-31 | Rp12.46 Trillion ≈ $730.33 Million |
Rp2.16 Trillion ≈ $126.56 Million |
0.173x | -22.85% |
| 2015-12-31 | Rp10.94 Trillion ≈ $640.94 Million |
Rp2.46 Trillion ≈ $143.97 Million |
0.225x | -4.79% |
| 2014-12-31 | Rp9.82 Trillion ≈ $575.27 Million |
Rp2.32 Trillion ≈ $135.72 Million |
0.236x | +116.28% |
| 2013-12-31 | Rp8.50 Trillion ≈ $498.06 Million |
Rp927.16 Billion ≈ $54.33 Million |
0.109x | -41.58% |
| 2012-12-31 | Rp7.37 Trillion ≈ $431.95 Million |
Rp1.38 Trillion ≈ $80.65 Million |
0.187x | -17.44% |
| 2011-12-31 | Rp6.52 Trillion ≈ $381.81 Million |
Rp1.47 Trillion ≈ $86.34 Million |
0.226x | +13.15% |
| 2010-12-31 | Rp5.77 Trillion ≈ $338.21 Million |
Rp1.15 Trillion ≈ $67.60 Million |
0.200x | -29.78% |
| 2009-12-31 | Rp4.79 Trillion ≈ $280.71 Million |
Rp1.36 Trillion ≈ $79.90 Million |
0.285x | +53.10% |
| 2008-12-31 | Rp4.34 Trillion ≈ $254.57 Million |
Rp807.70 Billion ≈ $47.33 Million |
0.186x | +105.77% |
| 2007-12-31 | Rp4.02 Trillion ≈ $235.36 Million |
Rp362.90 Billion ≈ $21.26 Million |
0.090x | -50.02% |
| 2006-12-31 | Rp3.54 Trillion ≈ $207.67 Million |
Rp640.61 Billion ≈ $37.54 Million |
0.181x | +15.14% |
| 2005-12-31 | Rp2.81 Trillion ≈ $164.74 Million |
Rp441.37 Billion ≈ $25.86 Million |
0.157x | -45.36% |
| 2004-12-31 | Rp1.48 Trillion ≈ $86.69 Million |
Rp425.07 Billion ≈ $24.91 Million |
0.287x | -42.02% |
| 2003-12-31 | Rp1.02 Trillion ≈ $59.97 Million |
Rp507.17 Billion ≈ $29.72 Million |
0.496x | -19.13% |
| 2002-12-31 | Rp651.41 Billion ≈ $38.17 Million |
Rp399.13 Billion ≈ $23.39 Million |
0.613x | +25.47% |
| 2001-12-31 | Rp345.97 Billion ≈ $20.27 Million |
Rp168.95 Billion ≈ $9.90 Million |
0.488x | +52.08% |
| 2000-12-31 | Rp305.74 Billion ≈ $17.91 Million |
Rp98.17 Billion ≈ $5.75 Million |
0.321x | -- |
About Kalbe Farma Tbk PT
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devi… Read more